ILMN

143.24

1.21% -1.76

Dopo l'orario di chiusura: 144.10 0.86 +0.60%

Illumina Inc (ILMN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ILMN Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$145.00

Aprire:

$149.45

Volume 24 ore:

2.01M

Relative Volume:

1.15

Capitalizzazione di mercato:

$21.67B

Reddito:

$4.39B

Utile/perdita netta:

$853.00M

Rapporto P/E:

26.00

EPS:

5.5097

Flusso di cassa netto:

$556.00M

1 W Prestazione:

+3.27%

1M Prestazione:

+9.91%

6M Prestazione:

+18.70%

1 anno Prestazione:

+83.15%

Intervallo 1D:

$142.97

$150.20

Intervallo di 1 settimana:

$134.67

$150.20

Portata 52W:

$78.55

$155.53

Illumina Inc Stock (ILMN) Company Profile

Nome

Illumina Inc

Settore

Healthcare (1106)

Industria

Diagnostics & Research (52)

Telefono

(858) 202-4500

Indirizzo

5200 ILLUMINA WAY, SAN DIEGO, CA

Dipendente

8,650

Cinguettio

@illumina

Prossima data di guadagno

2026-04-30

Ultimi documenti SEC

ILMN's Discussions on Twitter

Compare ILMN vs TMO, DHR, IDXX, WAT, A

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ILMN Illumina Inc	143.24	21.94B	4.39B	853.00M	556.00M	5.5097
TMO Thermo Fisher Scientific Inc	448.21	165.75B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	164.54	117.48B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	532.86	41.70B	4.45B	1.10B	1.06B	13.59
WAT Waters Corp	333.21	32.89B	3.77B	449.25M	240.68M	7.8556
A Agilent Technologies Inc	113.26	31.86B	7.07B	1.29B	993.00M	4.5355

Illumina Inc Stock (ILMN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-08-12	Downgrade	Daiwa Securities	Outperform → Neutral
2025-07-11	Downgrade	Scotiabank	Sector Outperform → Sector Perform
2025-03-04	Reiterato	Citigroup	Neutral
2025-02-28	Downgrade	HSBC Securities	Buy → Hold
2025-02-10	Downgrade	Barclays	Equal Weight → Underweight
2025-02-07	Downgrade	TD Cowen	Buy → Hold
2024-12-11	Downgrade	Citigroup	Buy → Neutral
2024-11-12	Ripresa	Morgan Stanley	Equal-Weight
2024-10-17	Aggiornamento	HSBC Securities	Hold → Buy
2024-08-28	Aggiornamento	Argus	Hold → Buy
2024-08-16	Aggiornamento	Daiwa Securities	Neutral → Buy
2024-08-14	Aggiornamento	Barclays	Underweight → Equal Weight
2024-08-14	Aggiornamento	TD Cowen	Hold → Buy
2024-07-10	Aggiornamento	Citigroup	Neutral → Buy
2024-06-03	Ripresa	Jefferies	Hold
2024-01-16	Downgrade	HSBC Securities	Buy → Hold
2024-01-04	Downgrade	TD Cowen	Outperform → Market Perform
2023-12-18	Aggiornamento	Scotiabank	Sector Perform → Sector Outperform
2023-12-15	Aggiornamento	Bernstein	Underperform → Mkt Perform
2023-12-14	Iniziato	Guggenheim	Buy
2023-12-14	Iniziato	Stephens	Overweight
2023-12-13	Iniziato	Wolfe Research	Outperform
2023-12-12	Downgrade	BofA Securities	Neutral → Underperform
2023-12-11	Aggiornamento	Citigroup	Sell → Neutral
2023-11-10	Downgrade	Canaccord Genuity	Buy → Hold
2023-09-28	Iniziato	Bernstein	Underperform
2023-07-05	Ripresa	JP Morgan	Neutral
2023-01-25	Downgrade	Argus	Buy → Hold
2023-01-05	Iniziato	Scotiabank	Sector Perform
2022-12-12	Downgrade	Citigroup	Neutral → Sell
2022-12-07	Iniziato	RBC Capital Mkts	Outperform
2022-10-04	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2022-09-28	Aggiornamento	Evercore ISI	In-line → Outperform
2022-08-25	Iniziato	Credit Suisse	Neutral
2022-07-13	Downgrade	Barclays	Equal Weight → Underweight
2022-01-18	Aggiornamento	Stifel	Hold → Buy
2022-01-11	Aggiornamento	Barclays	Underweight → Equal Weight
2022-01-07	Aggiornamento	BofA Securities	Underperform → Neutral
2022-01-06	Ripresa	Morgan Stanley	Equal-Weight
2022-01-06	Ripresa	Piper Sandler	Overweight
2021-10-15	Ripresa	Cowen	Outperform
2021-08-19	Downgrade	SVB Leerink	Outperform → Mkt Perform
2021-06-01	Aggiornamento	Evercore ISI	Underperform → In-line
2021-03-31	Downgrade	Atlantic Equities	Overweight → Neutral
2021-03-31	Aggiornamento	Canaccord Genuity	Hold → Buy
2021-03-03	Iniziato	Barclays	Underweight
2020-12-22	Aggiornamento	Piper Sandler	Neutral → Overweight
2020-12-17	Aggiornamento	BTIG Research	Neutral → Buy
2020-10-13	Downgrade	Guggenheim	Buy → Neutral
2020-09-30	Iniziato	Atlantic Equities	Overweight
2020-09-29	Downgrade	Wolfe Research	Outperform → Peer Perform
2020-09-22	Downgrade	Stifel	Buy → Hold
2020-09-22	Downgrade	UBS	Buy → Neutral
2020-09-21	Aggiornamento	Guggenheim	Neutral → Buy
2020-09-21	Downgrade	JP Morgan	Overweight → Neutral
2020-09-09	Iniziato	Morgan Stanley	Equal-Weight
2020-08-07	Downgrade	Evercore ISI	In-line → Underperform
2020-08-07	Downgrade	Piper Sandler	Overweight → Neutral
2020-07-07	Downgrade	Guggenheim	Buy → Neutral
2020-04-24	Downgrade	Citigroup	Buy → Neutral
2020-04-21	Downgrade	Robert W. Baird	Outperform → Neutral
2020-01-08	Iniziato	Wells Fargo	Underweight
2020-01-07	Iniziato	Citigroup	Buy
2020-01-02	Downgrade	Evercore ISI	Outperform → In-line
2019-11-15	Iniziato	Stifel	Buy
2019-10-25	Iniziato	Guggenheim	Buy

Mostra tutto

Illumina Inc Borsa (ILMN) Ultime notizie

07:42 AM

Illumina director Keith Meister sells $47.9m in shares - Investing.com

07:42 AM

07:26 AM

Illumina(ILMN.US) Director Sells US$47.93 Million in Common Stock - Moomoo

07:26 AM

07:21 AM

Corvex Funds tied to Illumina (NASDAQ: ILMN) sell shares and partly unwind equity swaps - Stock Titan

07:21 AM

05:23 AM

RBC Capital assumes Illumina stock coverage with outperform rating - Investing.com

05:23 AM

01:55 AM

[SCHEDULE 13G/A] ILLUMINA, INC. Amended Passive Investment Disclosure - Stock Titan

01:55 AM

01:53 AM

Illumina stock (US4523271090): Shares up 10.6% YTD amid strong earnings beat - AD HOC NEWS

01:53 AM

01:00 AM

Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight - GlobeNewswire Inc.

01:00 AM

07:49 AM

Here Are Thursday’s Top Wall Street Analyst Research Calls: Commercial Metals, Doximity, Draftkings, Hut 8, Illumina, Lowe’s, TeraWulf, Starbucks, Whirlpool, Wix.com, and More - Yahoo Finance

07:49 AM

07:42 AM

Daiwa Securities Upgrades Illumina to Outperform From Neutral, Adjusts Price Target to $155 From $128 - marketscreener.com

07:42 AM

07:31 AM

Bioinformatics Platforms Market Is Going to Boom | • Illumina Inc • Thermo Fisher Scientific Inc • QIAGEN N.V - openPR.com

07:31 AM

12:33 PM

ILMN Stock Analysis 2026: Should You Invest in Illumina Now? - sebd.in

12:33 PM

May 13, 2026

Number of shareholders of Illumina, Inc. – SIX:ILMN - TradingView

May 13, 2026

Illumina (ILMN) Form 144 lists 600,000 shares with Goldman Sachs broker - Stock Titan

May 13, 2026

Illumina stock (US4523271090): Q1 2026 earnings beat signals recovery momentum - AD HOC NEWS

May 13, 2026

Illumina stock (US4523271090): Consensus Hold rating reflects steady biotech positioning - AD HOC NEWS

May 13, 2026

May 12, 2026

The Bull Case For Illumina (ILMN) Could Change Following Upgraded 2026 Outlook And Major BuybackLearn Why - simplywall.st

May 12, 2026

Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch

May 12, 2026

Illumina stock (US4523271090): Analyst consensus shifts to Hold amid mixed signals - AD HOC NEWS

May 12, 2026

Illumina Inc. stock (US4523271090): Latest developments and business overview - AD HOC NEWS

May 12, 2026

SomaLogic stock (US82489T1043): Completed $350M sale to Illumina - AD HOC NEWS

May 12, 2026

Illumina Innovation Fund Iii, L.p. Net Worth (2026) - GuruFocus

May 12, 2026

May 11, 2026

How Illumina employees work to move healthcare toward precision medicine - Illumina

May 11, 2026

Corvex funds (NASDAQ: ILMN) exercise Illumina equity swaps, retain large position - Stock Titan

May 11, 2026

The future of global food security may depend on quality agrigenomics software - Illumina

May 11, 2026

NovaSeq X software update v1.4 improves data quality and customer usability - Illumina

May 11, 2026

Illumina stock (US4523271090): Q1 earnings beat lifts shares 8% YTD - AD HOC NEWS

May 11, 2026

We Think That There Are Issues Underlying Illumina's (NASDAQ:ILMN) Earnings - simplywall.st

May 11, 2026